Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome.

International urogynecology journal and pelvic floor dysfunction

Volumn 20, Issue 12, 2009, Pages 1431-1438

  Sand, Peter K ^a   Dmochowski, Roger R ^b   Zinner, Norman R ^b   Staskin, David R ^b   Appell, Rodney A ^b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; NORTROPANE DERIVATIVE; TROSPIUM CHLORIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MIDDLE AGED; MULTICENTER STUDY; OVERACTIVE BLADDER; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; NORTROPANES; PARASYMPATHOLYTICS; URINARY BLADDER, OVERACTIVE;

EID: 77953434559     PISSN: None     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-009-0969-8     Document Type: Article

References (0)